CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study.

Pubmed ID: 19761597

Pubmed Central ID: PMC2760546

Journal: BMC nephrology

Publication Date: Sept. 17, 2009

Affiliation: Division of Nephrology, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA. dweiner@tuftsmedicalcenter.org

MeSH Terms: Humans, Male, Female, Aged, Aged, 80 and over, Risk Factors, Middle Aged, Survival Analysis, Risk Assessment, Comorbidity, Kidney Failure, Chronic, Incidence, Stroke, Survival Rate, Sensitivity and Specificity, Glomerular Filtration Rate, Atherosclerosis, Boston, Reproducibility of Results

Grants: K23 DK71636, R21 DK068310, K23 DK071636, K23 DK071636-04, K24 DK078204

Authors: Tighiouart H, Weiner DE, Salem DN, Levey AS, Sarnak MJ, Krassilnikova M

Cite As: Weiner DE, Krassilnikova M, Tighiouart H, Salem DN, Levey AS, Sarnak MJ. CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study. BMC Nephrol 2009 Sep 17;10:26.

Studies:

Abstract

BACKGROUND: It is unknown whether defining chronic kidney disease (CKD) based on one versus two estimated glomerular filtration rate (eGFR) assessments changes the prognostic importance of reduced eGFR in a community-based population. METHODS: Participants in the Atherosclerosis Risk in Communities Study and the Cardiovascular Health Study were classified into 4 groups based on two eGFR assessments separated by 35.3 +/- 2.5 months: sustained eGFR < 60 mL/min per 1.73 m(2) (1 mL/sec per 1.73 m(2)); eGFR increase (change from below to above 60); eGFR decline (change from above to below 60); and eGFR persistently >or=60. Outcomes assessed in stratified multivariable Cox models included cardiac events and a composite of cardiac events, stroke, and mortality. RESULTS: There were 891 (4.9%) participants with sustained eGFR < 60, 278 (1.5%) with eGFR increase, 972 (5.4%) with eGFR decline, and 15,925 (88.2%) with sustained eGFR > 60. Participants with eGFR sustained < 60 were at highest risk of cardiac and composite events [HR = 1.38 (1.15, 1.65) and 1.58 (1.41, 1.77)], respectively, followed by eGFR decline [HR = 1.20 (1.00, 1.45) and 1.32 (1.17, 1.49)]. Individuals with eGFR increase trended toward increased cardiac risk [HR = 1.25 (0.88, 1.77)] and did not significantly differ from eGFR decline for any outcome. Results were similar when estimating GFR with the CKD-EPI equation. CONCLUSION: Individuals with persistently reduced eGFR are at highest risk of cardiovascular outcomes and mortality, while individuals with an eGFR < 60 mL/min per 1.73 m(2) at any time are at intermediate risk. Use of even a single measurement of eGFR to classify CKD in a community population appears to have prognostic value.